While immunotherapy has been groundbreaking in the treatment of stage 4 colorectal cancer, only about 15% of patients are found to be eligible for the treatment based on their protein screenings, Dr
(More information can be found in Foleys article GLP-1 Drugs: FDA Removes Semaglutide from the Drug Shortage List), The FDA has raised health and safety concerns about these compounded medications, citing issues such as dosing errors, poor inspection records from overseas manufacturers, and, in some instances, adverse events, some of which required medical intervention, These compounded medications are often inaccurately labeled as generic versions of semaglutide and tirzepatide injections and may contain additives, such as vitamins, which have not been approved by the FDA or evaluated through clinical trials, and The FDA has not approved any oral GLP-1 medications, nor has it approved the use of GLP-1 medications for cosmetic purposes
SS: Moving past a plateau begins with reassessing your plan: Is anything missing
These participants did not see their weight loss plateau, as has been a concern with existing GLP-1s